Results per Page:
Fred Hutch deploys AI technology to help analyze colonoscopies
GI Genius flags suspicious findings with a green square
50 years of doing hard things
Founded in 1975 to honor a brother, Fred Hutch Cancer Center pursued bold science, pioneered a cure for blood diseases that changed medicine and became a world-class biomedical research and clinical care institution
Fred Hutch receives funding to advance Indigenous cancer health equity
Cooperative agreement will support work on smoking cessation, lung cancer screening, patient navigation and more
10 years in, HICOR’s efforts boost cancer care’s value
Fred Hutch’s Value in Cancer Care Initiative celebrates a decade of data and crucial collaborations between providers, payers and patients
HIV’s secret sweet tooth: T cell glycosylation determines variant entry
From the Overbaugh Lab, Human Biology and Public Health Sciences Divisions
Barriers to adherence of 1-year surveillance colonoscopy for CRC patients
From the Issaka Lab, Public Health Sciences and Clinical Research Divisions
Playing hide-and-seek with DTCs: new CAR-T therapy reduces risk of recurrent breast cancer
From the Ghajar Lab, Human Biology and Public Health Sciences Divisions, and the Riddell Lab, Translational Science and Therapeutics Division
New funding drives six breast cancer studies
Scientists from Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium receive $1.7M in grants from Breast Cancer Research Foundation
Finding passion and community
Fred Hutch Postbaccalaureate Scholar Program bridges gap between college and graduate school for aspiring scientists
For Fred Hutch biostatisticians, numbers are no game
Meticulous work at the SWOG Statistics and Data Management Center, housed at Fred Hutch, may alter care for bladder cancer and lymphoma
Clinical cancer research in the U.S. is increasingly dominated by pharmaceutical industry sponsors, study finds
Study underscores need for increased investment in federally funded cancer clinical trials
Vaccine targets that accommodate evolving SARS-CoV-2 variants
From the Overbaugh Lab, Human Biology and Public Health Sciences Divisions
Menopausal hormone therapy may lower the risk of colorectal cancer
From the Peters and Hsu Groups, Cancer Consortium & Public Health Sciences Division
$5.25M from the Kuni Foundation propels innovative adult oncology research
Grants will support research on tumor regression, immunotherapy access and better care for breast, liver and peritoneal malignancies
Targeted new approach and computational tools reveal lung cancer subtypes hiding in patterns in cell-free DNA
Innovative strategy a step toward liquid biopsy to detect, monitor aggressive small cell lung cancer